Timeline
Market Brief: easyJet rejects Castlelake takeover bids, BATM Advanced Communications, Ondine Biomedical, Babcock International, Synthomer
Ondine Biomedical expects Phase 3 top-line results within three weeks
Health & Bio Today: Genedrive gains NHS traction in Manchester, Ondine Biomedical, Regional REIT
Ondine Biomedical nasal photodisinfection cuts brain surgery infections by 78.5%
Ondine Biomedical reports ICU feasibility study with signals of reduced pneumonia
Health & Bio Today: GSK drops despite strong Q1, SkinBioTherapeutics, Solvonis, AstraZeneca, Ondine Biomedical
Tech Today: Smarter Web, Sage, MedPal AI, Shearwater, ZOO Digital, AstraZeneca, Ondine Biomedical
The Premarket Brief: GSK, Lloyds, AstraZeneca, Prudential, Haleon, Ondine Biomedical, Halfords, Frasers Group, Treatt
Ondine Biomedical raises £5m at 12p to fund NDA preparation
Health & Bio Today: GSK's efimosfermin wins FDA Breakthrough and EMA PRIME status, PureTech Health, Ondine Biomedical, AstraZeneca
Ondine study shows 39.5% cut in ICU pneumonia and is accepted for CACCN oral presentation
The Premarket Brief: ECR Minerals, Ondine Biomedical, 88 Energy, Pathos Communications, Beowulf Mining
Ondine Biomedical (AIM:OBI) shares surged 7.4% after Ottawa Heart Institute study
Ondine Biomedical to showcase at World Congress on Infectious Diseases
Ondine-backed ICU pilot cuts pneumonia by 39.5% with five-minute nasal treatment
Ondine boosted by patient enrolment, revenues rise and factory upgrades begin
More in Telecoms
Vodafone Group shares soar after stake sale to Xavier Niel
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.